Careful characterization is needed to fully elucidate the meaning of these aberrations in mature B cell neoplasms, also in view of the well-established role of KRAS aberrations in promoting an immunosuppressive and tumor protective microenvironment in the context of solid tumors. This evidence concerns the gene KRAS and neoplasm.